IL-10 has been demonstrated to impair CD8 T cell function across various tumor types (42), while TGF-β undermines T-cell immunity by promoting regulatory T-cell differentiation, further enhancing immunosuppression within the tumor microenvironment (43). Here, TGFB1 is linked to neoplasm.